Huntington's disease: Molecular genetics, mutation and predictive testing

被引:0
|
作者
Zuhlke, C [1 ]
Thies, U [1 ]
机构
[1] UNIV GOTTINGEN,INST HUMANGENET,W-3400 GOTTINGEN,GERMANY
来源
NERVENARZT | 1996年 / 67卷 / 01期
关键词
Huntington's disease; unstable DNA; trinucleotide repeat; expansion; DNA diagnosis; predictive test; testing uptake;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Predictive genetic testing offers the opportunity for persons at risk to obtain information about their carrier status concerning Huntington's disease (HD). HD is associated with the expansion of a (GAG) repeat in the gene IT15. HD chromosomes contain about 40-75 repeat units, whereas normal chromosomes show a range between 11 and 33 repeats. The HD repeat is highly unstable during transmission, involving both increases and decreases in size with the largest expansions occurring in male meioses. The number of (CAG) copies is inversely correlated with the onset age of the disorder. Investigation of sporadic cases revealed that new mutations for HD are more frequent than estimated. Analysis of the repeat length allows direct DNA diagnosis of affected individuals and asymptomatic persons at risk. From 1989 to March 1993 in our institute predictive testing by indirect DNA methods was requested by 108 persons at risk. After cloning of the HD gene in 1993, direct testing was requested by 113 persons at risk between April 1993 and April 1994 in Gottingen. In about 400 patients differential diagnosis was performed with the direct method. In approximately 82% of the patients the expanded (CAG) repeat was found, and the HD diagnosis could be confirmed.
引用
收藏
页码:25 / 35
页数:11
相关论文
共 50 条
  • [21] Molecular Pathogenesis in Huntington’s Disease
    S. N. Illarioshkin
    S. A. Klyushnikov
    V. A. Vigont
    Yu. A. Seliverstov
    E. V. Kaznacheyeva
    Biochemistry (Moscow), 2018, 83 : 1030 - 1039
  • [22] Adverse psychological events occurring in the first year after predictive testing for Huntington's disease
    Lawson, K
    Wiggins, S
    Green, T
    Adam, S
    Bloch, M
    Hayden, MR
    JOURNAL OF MEDICAL GENETICS, 1996, 33 (10) : 856 - 862
  • [23] Reproductive decision making before and after predictive testing for Huntington's disease: an Australian perspective
    Richards, FH
    Rea, G
    CLINICAL GENETICS, 2005, 67 (05) : 404 - 411
  • [24] Psychological distress in the 5-year period after predictive testing for Huntington's disease
    Marleen Decruyenaere
    Gerry Evers-Kiebooms
    Trees Cloostermans
    Andrea Boogaerts
    Koen Demyttenaere
    René Dom
    Jean Pierre Fryns
    European Journal of Human Genetics, 2003, 11 : 30 - 38
  • [25] Psychological distress in the 5-year period after predictive testing for Huntington's disease
    Decruyenaere, M
    Evers-Kiebooms, G
    Cloostermans, T
    Boogaerts, A
    Demyttenaere, K
    Dom, R
    Fryns, JP
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2003, 11 (01) : 30 - 38
  • [26] Molecular Pathogenesis in Huntington's Disease
    Illarioshkin, S. N.
    Klyushnikov, S. A.
    Vigont, V. A.
    Seliverstov, Yu. A.
    Kaznacheyeva, E. V.
    BIOCHEMISTRY-MOSCOW, 2018, 83 (09) : 1030 - 1039
  • [27] The evaluation of the 'stages of change' model for use in counselling client's undergoing predictive testing for Huntington's disease
    Houlihan, GD
    JOURNAL OF ADVANCED NURSING, 1999, 29 (05) : 1137 - 1143
  • [28] Huntington's disease: New frontiers for molecular and cell therapy
    Melone, MAB
    Jori, FP
    Peluso, G
    CURRENT DRUG TARGETS, 2005, 6 (01) : 43 - 56
  • [29] Recommendations for the predictive genetic test in Huntington's disease
    MacLeod, R.
    Tibben, A.
    Frontali, M.
    Evers-Kiebooms, G.
    Jones, A.
    Martinez-Descales, A.
    Roos, R. A.
    CLINICAL GENETICS, 2013, 83 (03) : 221 - 231
  • [30] Somatosensory evoked potentials correlate with genetics in Huntington's disease
    Beniczky, S
    Kéri, S
    Antal, A
    Jakab, K
    Nagy, H
    Benedek, G
    Janka, Z
    Vécsei, L
    NEUROREPORT, 2002, 13 (17) : 2295 - 2298